Thrombosis remains a major contributor to cardiovascular diseases globally, yet current therapeutic strategies are hindered by narrow therapeutic windows, suboptimal thrombolytic efficacy, and inflammation-driven recurrence. Herein, we reported a second near-i... ...

请注册登录后继续浏览